Reversion of Multidrug Resistance Using Self-Organized Nanoparticles Holding Both Doxorubicin and Targeting Moiety

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|7|7|500-506

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.7, Iss.7, 2010-08, pp. : 500-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reversion of Multidrug Resistance in Tumor By Biocompatible Nanomaterials

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-07 ,pp. : 737-745

Bentham Science Publishers

Access to resources Recommend Favorite

Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles

By  

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6655-6666

Bentham Science Publishers

Access to resources Recommend Favorite

Liver Cancer Targeting of Doxorubicin with Reduced Distribution to the Heart Using Hematoporphyrin-Modified Albumin Nanoparticles in Rats

By Chang Ji-Eun   Shim Won-Sik   Yang Su-Geun   Kwak Eun-Young   Chong Saeho   Kim Dae-Duk   Chung Suk-Jae   Shim Chang-Koo  

Pharmaceutical Research, Vol. 29, Iss. 3, 2012-03 ,pp. : 795-805

Springer Publishing Company

Access to resources Recommend Favorite

Development of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 23 full-factorial design

By Haas Sandra Elisa   de Andrade Cristiane   Sansone Pedro Ernesto da Silva   Guterres Silvia   Dalla Costa Teresa  

Pharmaceutical Development and Technology, Vol. 19, Iss. 7, 2014-11 ,pp. : 769-778

Informa Healthcare

Access to resources Recommend Favorite

Research Spotlight: Targeting drug delivery systems for circumventing multidrug resistance of cancers

By Ju Rui-Jun   Mu Li-Min   Lu Wan-Liang  

Therapeutic Delivery, Vol. 4, Iss. 6, 2013-06 ,pp. : 667-671

Future Science

Access to resources Recommend Favorite